We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Methylation Profiling for Determining Gene Activity

By Biotechdaily staff writers
Posted on 01 Sep 2004
Researchers working with the plant Arabidopsis have used a powerful new microarray-based methylation profiling technology to study the role of epigenetic information in determining gene activity.

In their study, the investigators at Cold Spring Harbor Laboratory (NY, USA) utilized the MethylScope technology of Orion Genomics (Saint Louis, MO, USA). More...
MethylScope employs a microarray analysis technique to assess to what extent genes in a genome are methylated. The technology relies on proprietary methods to divide genomic DNA into two fractions: methylated and unmethylated.

Each fraction is labeled with a different color of fluorescent dye (e.g., unmethylated DNA is green and methylated DNA is red and is then hybridized to a microarray. If an array feature corresponding to a single gene in the genome glows red, then that gene was methylated in the tissue from which the DNA was prepared. If, however, an array feature glows green, then that gene was unmethylated. Observing the red-green ratio for each feature on an array allows investigators to quantitatively determine the degree to which a gene may be methylated.


The investigators reported in the August 6, 2004, issue of Nature that the DNA sequences at the sites of transposon activity correspond to small interfering RNAs (siRNAs). They also showed that transposable elements could regulate genes epigenetically, but only when inserted within or very close to them.

"Our research concerns the mechanism by which methylated DNA and other epigenetic information determines gene activity,” said senior author Dr. Rob Martienssen, a professor at Cold Spring Harbor Laboratory and co-founder of Orion Genomics. "Because of this ‘second code,' epigenetic changes are emerging as important defects in childhood diseases as well as in cancer. The profiling technology described in this paper will help to uncover these epigenetic defects, providing biomarkers and leads for potential therapy.”





Related Links:
Cold Springs Harbor Laboratory
Orion Genomics

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.